Platinum Investment Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13M | Buy |
195,727
+38,738
| +25% | +$620K | 0.21% | 46 |
|
|
2025
Q1 | $2.68M | Sell |
156,989
-45,334
| -22% | -$775K | 0.16% | 44 |
|
|
2024
Q4 | $5.01M | Buy |
202,323
+10,081
| +5% | +$250K | 0.29% | 35 |
|
|
2024
Q3 | $5.48M | Hold |
192,242
| – | – | 0.25% | 37 |
|
|
2024
Q2 | $5.08M | Buy |
192,242
+1,586
| +0.8% | +$41.9K | 0.21% | 37 |
|
|
2024
Q1 | $6.16M | Sell |
190,656
-38,109
| -17% | -$1.23M | 0.25% | 37 |
|
|
2023
Q4 | $9.64M | Buy |
228,765
+2,826
| +1% | +$119K | 0.39% | 40 |
|
|
2023
Q3 | $8.67M | Sell |
225,939
-102,903
| -31% | -$3.95M | 0.34% | 37 |
|
|
2023
Q2 | $6.24M | Sell |
328,842
-18,128
| -5% | -$344K | 0.22% | 51 |
|
|
2023
Q1 | $5.38M | Sell |
346,970
-64,327
| -16% | -$998K | 0.19% | 54 |
|
|
2022
Q4 | $7.3M | Sell |
411,297
-247,778
| -38% | -$4.4M | 0.28% | 44 |
|
|
2022
Q3 | $3.68M | Sell |
659,075
-118,515
| -15% | -$661K | 0.15% | 55 |
|
|
2022
Q2 | $3.03M | Buy |
777,590
+90,930
| +13% | +$355K | 0.11% | 66 |
|
|
2022
Q1 | $3.78M | Buy |
686,660
+70,760
| +11% | +$390K | 0.12% | 63 |
|
|
2021
Q4 | $5.25M | Buy |
615,900
+60,835
| +11% | +$518K | 0.15% | 61 |
|
|
2021
Q3 | $4.82M | Buy |
+555,065
| New | +$4.82M | 0.14% | 66 |
|